Today, PolyVascular is excited to announce a strategic collaboration with CobiCure which includes advisory and strategic expertise, along with $2 million in grant funding. CobiCure is a non-profit pediatric initiative with a mission to solve unmet needs in pediatric medicine by accelerating the advancement of life-changing medical technologies to improve the lives of children suffering from rare and underserved conditions.

“CobiCure’s mission and vision were a perfect match for PolyVascular’s goal to eliminate repeat surgeries in children with congenital heart disease,” said Will Clifton, MD, Chief Operating Officer at PolyVascular. “With this partnership, we are one step closer to reaching this vulnerable population and improving their quality of life.”